These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25070156)

  • 1. Blood loses it when nerves go bad.
    Baryawno N; Scadden DT
    Cell Res; 2014 Oct; 24(10):1151-2. PubMed ID: 25070156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms.
    Arranz L; Sánchez-Aguilera A; Martín-Pérez D; Isern J; Langa X; Tzankov A; Lundberg P; Muntión S; Tzeng YS; Lai DM; Schwaller J; Skoda RC; Méndez-Ferrer S
    Nature; 2014 Aug; 512(7512):78-81. PubMed ID: 25043017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hematopoietic Microenvironment in Myeloproliferative Neoplasms: The Interplay Between Nature (Stem Cells) and Nurture (the Niche).
    Zhan H; Kaushansky K
    Adv Exp Med Biol; 2020; 1273():135-145. PubMed ID: 33119879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow niches in myeloid neoplasms.
    Kitagawa M; Kurata M; Onishi I; Yamamoto K
    Pathol Int; 2020 Feb; 70(2):63-71. PubMed ID: 31709722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploitation of the neural-hematopoietic stem cell niche axis to treat myeloproliferative neoplasms.
    Herlihy N; Harrison CN; McLornan DP
    Haematologica; 2019 Apr; 104(4):639-641. PubMed ID: 30930333
    [No Abstract]   [Full Text] [Related]  

  • 6. The Hematopoietic Niche in Myeloproliferative Neoplasms.
    Schmitt-Graeff AH; Nitschke R; Zeiser R
    Mediators Inflamm; 2015; 2015():347270. PubMed ID: 26696752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK2
    Zhan H; Ma Y; Lin CH; Kaushansky K
    Leukemia; 2016 Dec; 30(12):2332-2341. PubMed ID: 27133820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche.
    Hanoun M; Zhang D; Mizoguchi T; Pinho S; Pierce H; Kunisaki Y; Lacombe J; Armstrong SA; Dührsen U; Frenette PS
    Cell Stem Cell; 2014 Sep; 15(3):365-375. PubMed ID: 25017722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic nerves stimulate bone marrow function after chemotherapy.
    Cancer Discov; 2013 Jul; 3(7):OF15. PubMed ID: 23847358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mutations in the bone marrow microenvironment and dysregulated hematopoiesis.
    Miller LH; Qu CK; Pauly M
    Exp Hematol; 2018 Oct; 66():17-26. PubMed ID: 30076950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche.
    Méndez-Ferrer S; Michurina TV; Ferraro F; Mazloom AR; Macarthur BD; Lira SA; Scadden DT; Ma'ayan A; Enikolopov GN; Frenette PS
    Nature; 2010 Aug; 466(7308):829-34. PubMed ID: 20703299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow niche dysregulation in myeloproliferative neoplasms.
    Curto-Garcia N; Harrison C; McLornan DP
    Haematologica; 2020 May; 105(5):1189-1200. PubMed ID: 32241851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of inflammation in the biology of myeloproliferative neoplasms.
    Koschmieder S; Chatain N
    Blood Rev; 2020 Jul; 42():100711. PubMed ID: 32505517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interdependence of hematopoietic stem cells and their niche in oncogene promotion of myeloproliferative neoplasms: the 159th biomedical version of "it takes two to tango".
    Zhan H; Kaushansky K
    Exp Hematol; 2019 Feb; 70():24-30. PubMed ID: 30593829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.
    Yung Y; Lee E; Chu HT; Yip PK; Gill H
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33440869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche.
    Maryanovich M; Zahalka AH; Pierce H; Pinho S; Nakahara F; Asada N; Wei Q; Wang X; Ciero P; Xu J; Leftin A; Frenette PS
    Nat Med; 2018 Jun; 24(6):782-791. PubMed ID: 29736022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal exposure to fine particulate matter during pregnancy induces progressive senescence of hematopoietic stem cells under preferential impairment of the bone marrow microenvironment and aids development of myeloproliferative disease.
    Bhattarai G; Lee JB; Kim MH; Ham S; So HS; Oh S; Sim HJ; Lee JC; Song M; Kook SH
    Leukemia; 2020 May; 34(5):1481-1484. PubMed ID: 31776468
    [No Abstract]   [Full Text] [Related]  

  • 18. Myeloproliferative neoplasm stem cells.
    Mead AJ; Mullally A
    Blood; 2017 Mar; 129(12):1607-1616. PubMed ID: 28159736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of chronic myeloproliferative syndromes using the technics of in vitro hematopoiesis (the origin and function of marrow stromal cells in CML)].
    Takahashi M; Fujiwara M
    Rinsho Ketsueki; 1988 Jul; 29(7):994-1000. PubMed ID: 3184486
    [No Abstract]   [Full Text] [Related]  

  • 20. Myeloid malignancies and the microenvironment.
    Korn C; Méndez-Ferrer S
    Blood; 2017 Feb; 129(7):811-822. PubMed ID: 28064238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.